Increasing availability of cannabis products for research purposes

(a) In general The Secretary of Health and Human Services (referred to in this section as the Secretary), acting through the Director of the National Institutes of Health and in collaboration with the Commissioner of Food and Drugs and the Attorney General, shall take steps to increase the availability and diversity of research grade cannabis products for intramural and extramural research activities, including cannabis products with varied cannabinoid concentrations and cannabis products that reflect regional differences in products available to be sold directly to consumers. (b) Guidance In carrying out subsection (a), the Secretary may develop guidance clarifying how entities engaged in extramural research supported by the Federal Government may access cannabis products available to be sold directly to consumers. (c) Congressional briefing Not later than 1 year after the date of enactment of this Act, the Secretary shall brief the Committee on Health, Education, Labor, and Pensions and the Committee on the Judiciary of the Senate and the Committee on Energy and Commerce and the Committee on the Judiciary of the House of Representatives on the activities under subsection (a). (d) Funding In addition to amounts otherwise available, there is appropriated, out of any funds in the Treasury not otherwise appropriated, $275,000,000 for each of fiscal years 2026 through 2030 to carry out this section.